Risk scoring system for prediction of contrastinduced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention

Singapore Medical Journal

Volumn 53, Issue 3, 2012, Pages 164-169

  Chong, E ^a,b,c   Shen, L ^b   Poh, K K ^b,c   Tan, H C ^c  

^a ALEXANDRA HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Contrast induced nephropathy; Renal impairment; Risk score

Indexed keywords

ACETYLCYSTEINE; CREATINE KINASE; IOHEXOL; SODIUM CHLORIDE;

ADULT; AGE; AGED; ANEMIA; ARTICLE; COHORT ANALYSIS; CONTRAST INDUCED NEPHROPATHY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYDRATION; HYPOTENSION; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM;

ACUTE KIDNEY INJURY; AGE FACTORS; ANALYSIS OF VARIANCE; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; CONFIDENCE INTERVALS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; ODDS RATIO; PATIENT SAFETY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 84858222815     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mehran R. Contrast-induced nephropathy remains a serious complication of PCI. J Interv Cardiol 2007; 20:236-240.
2. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989; 320:143-149.
3. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130:461-470.
4. Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004:6; 44:1393-1399.
5. Van de Werf F, Ardissino D, Betriu A. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Forceon the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24:28-66.
6. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004; 110:588-636.
7. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 Guideline for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. J Am Coll Cardiol 2006; 47:216-235.
8. Goldfarb S, McCullough PA, McDermott J, Gay SB. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology and interventional cardiology. Mayo Clin Proc 2009; 84:170-179.
9. Mager A, Vaknin Assa H, Lev EI, et al. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction. Catheter Cardiovasc Interv 2011; 78:198-201.
10. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105:2259-2264.
11. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36:1542-1548.
12. Gomes VO, Blaya P, Poli de Figueiredo CE, Manfroi W, Caramori P. Contrastmedia induced nephropathy in patients undergoing coronary angiography. J Invasive Cardiol 2003; 15:304-310.
13. Wison S, Foo K, Cunningham J, et al. Renal function and risk stratification in acute coronary syndromes Am J Cardiol 2003; 91:1051-1054.
14. Santopinto JJ, Fox KA, Goldberg RJ, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart 2003; 89:1003-1008.
15. Zoungas S, Ninomiya T, Huxley R, et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009; 151:631-638.
16. Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004;110:2837-2842.
17. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrastinduced nephropathy in primary angioplasty. N Engl J Med 2006: 29; 354:2773-2782.
18. Shiragami K, Fujii Z, Sakumura T, et al. Effect of a contrast agent on longterm renal function and the efficacy of prophylactic hemodiafiltration. Circ J 2008; 72:427-433.
19. Solomon R. Preventing contrast-induced nephropathy: problems, challenges and future directions. BMC Med 2009; 13:7-24.
20. Chong E, Poh KK, Liang S, Tan HC. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine. Ann Acad Med Singapore 2010; 39:374-380.
21. Calvin AD, Misra S, Pflueger A. Contrast-induced acute kidney injury and diabetic nephropathy. Nat Rev Nephrol. 2010; 6:679-688.
22. Solomon RJ, Mehran R, Natarajan MK et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol. 2009; 4:1162-1169.
23. Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Catheter Cardiovasc Interv 2008; 71:62-72.
24. Rosenstock JL, Gilles E, Geller AB, et al. Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Int Urol Nephrol 2010; 42:1049-1054
25. McCullough PA, Adam A, Becker CR, et al. Risk prediction of contrastinduced nephropathy. Am J Cardiol 2006; 98:27K-36K.